Cargando…

Comprehensive evaluation of cell death-related genes as novel diagnostic biomarkers for breast cancer

BACKGROUND: Breast cancer (BRCA) ranks first among cancers in terms of incidence and mortality rates in women, primarily owing to metastasis, chemo-resistance, and heterogeneity. To predict long-term prognosis and design novel therapies for BRCA, more sensitive markers need to be explored. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Xiaoyue, Ding, Hao, Tao, Jing, Zhu, Yanhui, Zhang, Xiaoqiang, He, Gao, Yang, Junzhe, Wu, Xian, Liu, Xiaoan, Yu, Xiafei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643282/ https://www.ncbi.nlm.nih.gov/pubmed/38027811 http://dx.doi.org/10.1016/j.heliyon.2023.e21341

Ejemplares similares

LHX2 Is a Potential Biomarker and Associated with Immune Infiltration in Breast Cancer
por: Zhang, Ziwei, et al.
Publicado: (2023)

Comprehensive Analysis of the Immune-Oncology Targets and Immune Infiltrates of N(6)-Methyladenosine-Related Long Noncoding RNA Regulators in Breast Cancer
por: Zhang, Xiaoqiang, et al.
Publicado: (2021)

Comprehensive analysis of pyroptotic gene prognostic signatures associated with tumor immune microenvironment and genomic mutation in breast cancer
por: Zhang, Hongfei, et al.
Publicado: (2022)

Integrated tumor genomic and immune microenvironment analysis identifies predictive biomarkers associated with the efficacy of neoadjuvant therapy for triple‐negative breast cancer
por: Zhu, Yanhui, et al.
Publicado: (2022)

Deubiquitinase USP19 modulates apoptotic calcium release and endoplasmic reticulum stress by deubiquitinating BAG6 in triple negative breast cancer
por: Zhang, Xiaoqiang, et al.
Publicado: (2023)

The Efficacy and Toxicity of Neoadjuvant Chemotherapy Regimens of Epirubicin Plus Cyclophosphamide Followed by Docetaxel or Paclitaxel in Female Breast Cancer Patients
por: Wu, Xian, et al.
Publicado: (2021)

Crosstalk of RNA methylation writers defines tumor microenvironment and alisertib resistance in breast cancer
por: Zhang, Xiaoqiang, et al.
Publicado: (2023)

Effects of Chemotherapy on Serum Lipids in Chinese Postoperative Breast Cancer Patients
por: Lu, Qi, et al.
Publicado: (2020)

Peripheral inflammation/immune indicators of chemosensitivity and prognosis in breast cancer patients treated with neoadjuvant chemotherapy
por: Qian, Yi, et al.
Publicado: (2018)

Plasma tRNA Fragments Derived from 5′ Ends as Novel Diagnostic Biomarkers for Early-Stage Breast Cancer
por: Wang, Jingyi, et al.
Publicado: (2020)

Obtaining a Reliable Diagnostic Biomarker for Diabetes Mellitus by Standardizing Salivary Glucose Measurements
por: Cui, Yangyang, et al.
Publicado: (2022)

Actinin-4 as a Diagnostic Biomarker in Serum of Breast Cancer Patients
por: Fang, Cheng, et al.
Publicado: (2019)

Comprehensive Genomic Analysis for Identifying FZD6 as a Novel Diagnostic Biomarker for Acute Myeloid Leukemia
por: Yang, Li, et al.
Publicado: (2022)

A comprehensive analysis of microRNAs as diagnostic biomarkers for asthma
por: Xu, Li, et al.
Publicado: (2020)

Radiogenomics analysis reveals the associations of dynamic contrast-enhanced–MRI features with gene expression characteristics, PAM50 subtypes, and prognosis of breast cancer
por: Ming, Wenlong, et al.
Publicado: (2022)

Comprehensive analysis of the m6A-related molecular patterns and diagnostic biomarkers in osteoporosis
por: Bai, Qiong, et al.
Publicado: (2022)

Imaging Biomarkers as Predictors for Breast Cancer Death
por: Wu, Wendy Yi-Ying, et al.
Publicado: (2019)

Cross-platform genomic identification and clinical validation of breast cancer diagnostic biomarkers
por: Liu, Dongdong, et al.
Publicado: (2021)

Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma
por: Li, Jingyuan, et al.
Publicado: (2020)

Bioinformatics Analysis of Immune Cell Infiltration and Diagnostic Biomarkers between Ankylosing Spondylitis and Inflammatory Bowel Disease
por: Zhang, Xuhong, et al.
Publicado: (2023)

Comprehensive analysis to identify the neurotransmitter receptor-related genes as prognostic and therapeutic biomarkers in hepatocellular carcinoma
por: Wang, Xiaoqiang, et al.
Publicado: (2022)

Identification of early diagnostic biomarkers for breast cancer through bioinformatics analysis
por: Yan, Shaozhang, et al.
Publicado: (2023)

Comprehensive profiling of circular RNA expressions reveals potential diagnostic and prognostic biomarkers in multiple myeloma
por: Zhou, Fan, et al.
Publicado: (2020)

The prenatal diagnostic indicators of placenta accreta spectrum disorders
por: Wu, Xiafei, et al.
Publicado: (2023)

Serum semaphorin4C as an auxiliary diagnostic biomarker for breast cancer
por: Wang, Ya, et al.
Publicado: (2021)

Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers
por: Hamam, Rimi, et al.
Publicado: (2017)

Cellular hierarchy framework based on single-cell/multi-patient sample sequencing reveals metabolic biomarker PYGL as a therapeutic target for HNSCC
por: Guan, Jiezhong, et al.
Publicado: (2023)

Diagnostic, Prognostic, and Predictive Biomarkers in Breast Cancer
por: Li, Chia-Jung, et al.
Publicado: (2020)

Cytokine-induced apoptosis inhibitor 1: a comprehensive analysis of potential diagnostic, prognosis, and immune biomarkers in invasive breast cancer
por: Luo, Zhiwen, et al.
Publicado: (2023)

Comprehensive Assessment of Plasma Circ_0004771 as a Novel Diagnostic and Dynamic Monitoring Biomarker in Gastric Cancer
por: Xu, Yanhua, et al.
Publicado: (2020)

Advances on diagnostic biomarkers of pancreatic ductal adenocarcinoma: A systems biology perspective
por: Zhang, Wu-Hu, et al.
Publicado: (2020)

MicroRNA-98-5p inhibits human mesangial cell proliferation and TNF-α and IL-6 secretion by targeting BTB and CNC homology 1
por: Du, Yong, et al.
Publicado: (2021)

Comprehensive molecular biomarker identification in breast cancer brain metastases
por: Schulten, Hans-Juergen, et al.
Publicado: (2017)

KLF2 is a clinical diagnostic and treatment biomarker of breast cancer
por: Li, Ya-Zhao, et al.
Publicado: (2023)

Identification of circular RNAs as a promising new class of diagnostic biomarkers for human breast cancer
por: Lü, Lingshuang, et al.
Publicado: (2017)

Comprehensive assessment of cellular senescence in the tumor microenvironment
por: Wang, Xiaoman, et al.
Publicado: (2022)

Unsupervised Analysis Based on DCE-MRI Radiomics Features Revealed Three Novel Breast Cancer Subtypes with Distinct Clinical Outcomes and Biological Characteristics
por: Ming, Wenlong, et al.
Publicado: (2022)

Assessing Effect Modification of Excess Winter Death by Causes of Death and Individual Characteristics in Zhejiang Province, China: A Multi-Community Case-Only Analysis
por: He, Yiling, et al.
Publicado: (2018)

Comprehensive review of diagnostic modalities for early chronic pancreatitis
por: Ge, Qi-Chao, et al.
Publicado: (2021)

Breast Cancer; Discovery of Novel Diagnostic Biomarkers, Drug Resistance, and Therapeutic Implications
por: Afzal, Samia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_en87fu8def1td9jnma24cl8hmm